Related Experiment Video
Updated: Mar 12, 2026
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Targeting of AMP-activated protein kinase: prospects for computer-aided drug design
Joungmok Kim1, Goowon Yang2, Joohun Ha2
1a Department of Oral Biochemistry and Molecular Biology, School of Dentistry , Kyung Hee University , Dongdaemun-gu , Republic of Korea.
Introduction:
Dysregulation of energy homeostasis has been implicated in a number of human chronic diseases including diabetes, obesity, cancer, and inflammation. Given the functional attributes as a central regulator of energy homeostasis, AMP-activated protein kinase (AMPK) is emerging as a therapeutic target for these diseases, and lines of evidence have highlighted the need for rational and robust screening systems for identifying specific AMPK modulators with a therapeutic potential for preventing and/or curing these diseases. Areas covered: Here, the authors review the recent advances in the understanding of three-dimensional structures of AMPK in relationship with the regulatory mechanisms, potentials of AMPK as a therapeutic target in human chronic diseases, and prospects of computer-based drug design for AMPK. Expert opinion: Accumulating information of AMPK structure has provided us with deep insight into the molecular basis underlying the regulatory mechanisms, and further discloses several structural domains, which can be served for a target site for computer-based drug design. Molecular docking and simulations provides useful information about the binding sites between potent drugs and AMPK as well as a rational screening format to discover isoform-specific AMPK modulators. For these reasons, the authors suggest that computer-aided virtual screening methods hold promise as a rational approach for discovering more specific AMPK modulators.
Insights
AMP-activated protein kinase (AMPK) is a key regulator of energy homeostasis and a therapeutic target for chronic diseases. Computer-aided drug design offers a promising approach for discovering specific AMPK modulators.
Area of Science:
- Biochemistry
- Pharmacology
- Computational Biology
Background:
- Energy homeostasis dysregulation is linked to chronic diseases like diabetes, obesity, cancer, and inflammation.
- AMP-activated protein kinase (AMPK) is a central regulator of energy homeostasis, making it a potential therapeutic target.
- Robust screening systems are needed to identify specific AMPK modulators for disease prevention and treatment.
Purpose of the Study:
- To review recent advances in understanding AMPK structure and regulatory mechanisms.
- To explore the potential of AMPK as a therapeutic target in human chronic diseases.
- To discuss the prospects of computer-based drug design for identifying AMPK modulators.
Main Methods:
- Review of current literature on AMPK structure, regulation, and therapeutic potential.
- Analysis of computer-based drug design strategies, including molecular docking and simulations.
- Evaluation of virtual screening methods for discovering isoform-specific AMPK modulators.
Main Results:
- Advances in understanding AMPK's three-dimensional structures provide insights into its regulatory mechanisms.
- Specific structural domains of AMPK can be targeted for computer-based drug design.
- Molecular docking and simulations reveal binding sites and facilitate rational screening for potent AMPK modulators.
Conclusions:
- Computer-aided virtual screening holds promise for discovering specific AMPK modulators.
- Understanding AMPK structure is crucial for developing targeted therapies for chronic diseases.
- Isoform-specific AMPK modulators can be identified using computational approaches.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
01:25cAMP-dependent Protein Kinase Pathways
01:26Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:28Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
01:29Pharmacogenomics: Identification of New Drug Targets
01:22Amplifying Signals via Enzymatic Cascade